[0210157825] CAS 59-92-7 | L-β-3,4-Dihydroxyphenylalanine, 25 g | MP bio

Brand: MP Bio

59-92-7 /

  •  Size Guide

    Size Guide

  •  Delivery & Return
    납기
    국내재고 평균 3-5일
    해외재고 평균 3-4주

    견적/주문 요청시 담당자가 확인 후 예상 납기를 안내드립니다

    배송비

    유해화학물, 액체(유리병) : 평균 6,000원(vat별도) ~
    기존화학물, 고체(PE 포장) : 평균 3,000원(vat별도) ~
    견적/주문 요청시 담당자가 확인 후 정확한 배송비를 안내드립니다
  ... people are viewing this right now

  Share
Guaranteed Safe CheckoutTrust

0210157825 | CAS 59-92-7 | L-β-3,4-Dihydroxyphenylalanine, 25 g | MP bio

관련 문서 다운로드 (MSDS, COA, SPEC, Datasheet, Brochures, Manuals) :

  

SKU 0210157825
Alternate Names 3-(3,4-Dihydroxyphenyl)-L-alanine; L-3-Hydroxytyrosine; L-DOPA; Levodopa
Application Notes L-beta-3,4-Dihydroxyphenylalanine used in treatment of Parkinsonism. Also an inhibitor of tyrosine aminotransferase.
Base Catalog Number 10157825
Beilstein Registry Number 2215169
Biochemical Physiological Actions Natural isomer of the immediate precursor of dopamine; product of tyrosine hydroxylase
CAS # 59-92-7
EC Number 200-445-2
Extinction Coefficient EmM= 2.63 (280 nm); 6.17 (220.5 nm) (Lit.)
Format Powder
Hazard Statements H302-H315-H319-H335
Melting Point 276-278 °C(Lit.)
Molecular Formula C9H11NO4
Molecular Weight 197.19
Pack Size 25 g
Personal Protective Equipment Dust mask , Eyeshields, Gloves
pKa pKa(25 °C): 2.3, 8.7, 9.7, 13.4 (Lit.)
Purity ≥99.0%
RTECS Number AY5600000
Safety Symbol GHS07
Solubility Soluble in 0.5M HCl(50 mg/mL).
Usage Statement Unless specified otherwise, MP Biomedical’s products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
brand

MP Bio

SKU: 0210157825 Categories: , Brand:
My Cart
Recently Viewed
Compare Products (0 Products)
Compare Product
Compare Product
Compare Product
Compare Product
Categories
카카오톡 채널 상담하기
카카오톡 채널 친구추가
[0210157825] CAS 59-92-7 | L-β-3,4-Dihydroxyphenylalanine, 25 g | MP bio

[0210157825] CAS 59-92-7 | L-β-3,4-Dihydroxyphenylalanine, 25 g | MP bio

Request a Call Back